Back to mobile site

PDL BioPharma (PDLI) Sells Rights to IV Busulfex or $200M

December 17, 2007 9:05 AM EST Send to a Friend
Otsuka Pharmaceutical Co., Ltd. and PDL BioPharma, Inc. (Nasdaq ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login